Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research |
Washington University / Kimberly Johnson Ph.D. |
Epidemiology Grants |
2012 |
Missouri |
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma |
Dana-Farber Cancer Institute / Kimberly Stegmaier, MD |
Bridge Grants |
2012 |
Massachusetts |
Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML |
Fred Hutchinson Cancer Research Center / Phoenix Ho |
Young Investigator Grants |
2012 |
Washington |
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2012 |
Pennsylvania |
Improving Thymus Function by RB Inactivation |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Julien Sage, PhD |
Springboard Grants |
2012 |
California |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |